mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
968 |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.7 |
mRNA |
BRD-K48477130 |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.7 |